Regional activation of chromosomal arm 7q with and without gene amplification in taxane-selected human ovarian cancer cell lines

Genes Chromosomes and Cancer

Volumn 45, Issue 4, 2006, Pages 365-374

  Wang, Yan C ^a   Juric, Dejan ^a   Francisco, Brian ^a   Yu, Ron X ^a   Duran, George E ^a   Chen, G Kevin ^a   Chen, Xin ^a   Sikic, Branimir I ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA; GLYCOPROTEIN P; HISTONE; TAXANE DERIVATIVE;

ARTICLE; CANCER CELL CULTURE; CDK6 GENE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME 7Q; CLDNI2 GENE; CROT GENE; CULTURE MEDIUM; DNA MICROARRAY; DNA MODIFICATION; GENE; GENE ACTIVATION; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE NUMBER; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; MDRI GENE; MGC4175 GENE; MULTIDRUG RESISTANCE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN MODIFICATION; SRI GENE;

CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENES, MDR; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; PACLITAXEL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TAXOIDS;

EID: 33644756522     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20300     Document Type: Article

References (38)

1. Agarwal R, Kaye SB. 2003. Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer 3:502-516.
2. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511.
3. Baker EK, El-Osta A. 2003. The rise of DNA methylation and the importance of chromatin on multidrug resistance in cancer. Exp Cell Res 290:177-194.
4. Boutanaev AM, Kalmykova AI, Shevelyov YY, Nurminsky DI. 2002. Large clusters of co-expressed genes in the Drosophila genome. Nature 420:666-669.
5. Caron H, van Schaik B, van der Mee M, Baas F, Riggins G, van Sluis P, Hermus MC, van Asperen R, Boon K, Voute PA, Heisterkamp S, van Kampen A, Versteeg R. 2001. The human transcriptome map: clustering of highly expressed genes in chromosomal domains. Science 291:1289-1292.
6. Chang CF, Wai KM, Patterton HG. 2004. Calculating the statistical significance of physical clusters of co-regulated genes in the genome: the role of chromatin in domain-wide gene regulation. Nucleic Acids Res 32:1798-1807.
7. Chen G, Jaffrezou JP, Fleming WH, Duran GE, Sikic BI. 1994. Prevalence of multidrug resistance related to activation of the mdr1 gene in human sarcoma mutants derived by single-step doxorubicin selection. Cancer Res 54:4980-4987.
8. Chen GK, Duran GE, Mangili A, Beketic-Oreskovic L, Sikic BI. 2000. MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells. Br J Cancer 83:892-898.
9. Chen GK, Lacayo NJ, Duran GE, Wang Y, Bangs CD, Rea S, Kovacs M, Cherry AM, Brown JM, Sikic BI. 2002. Preferential expression of a mutant allele of the amplified MDR1 (ABCB1) gene in drug-resistant variants of a human sarcoma. Genes Chromosomes Cancer 34:372-383.
10. Chen GK, Sale S, Tan T, Ermoian RP, Sikic BI. 2004. CCAAT/enhancer- binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells. Mol Pharmacol 65:906-916.
11. Cohen BA, Mitra RD, Hughes JD, Church GM. 2000. A computational analysis of whole-genome expression data reveals chromosomal domains of gene expression. Nat Genet 26:183-186.
12. Dumontet C, Duran GE, Steger KA, Beketic-Oreskovic L, Sikic BI. 1996. Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol). Cancer Res 56:1091-1097.
13. Eisen MB, Spellman PT, Brown PO, Botstein D. 1998. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868.
14. Gottesman MM, Pastan I, Ambudkar SV. 1996. P-glycoprotein and multidrug resistance. Curr Opin Genet Dev 6:610-617.
15. Guastalla JP, 3rd, Dieras V. 2003. The taxanes: toxicity and quality of life considerations in advanced ovarian cancer. Br J Cancer 89(Suppl 3):S16-S22.
16. Huang X, Ushijima K, Komai K, Takemoto Y, Motoshima S, Kamura T, Kohno K. 2004. Co-expression of Y box-binding protein-1 and P-glycoprotein as a prognostic marker for survival in epithelial ovarian cancer. Gynecol Oncol 93:287-291.
17. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ. 2004. Cancer statistics, 2004. CA Cancer J Clin 54:8-29.
18. Kluger Y, Yu H, Qian J, Gerstein M. 2003. Relationship between gene co-expression and probe localization on microarray slides. BMC Genomics 4:49.
19. Knutsen T, Mickley LA, Ried T, Green ED, du Manoir S, Schrock E, Macville M, Ning Y, Robey R, Polymeropoulos M, Torres R, Fojo T. 1998. Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALL. Genes Chromosomes Cancer 23:44-54.
20. Kowenz-Leutz E, Leutz A. 1999. A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes. Mol Cell 4:735-743.
21. Lau DH, Lewis AD, Ehsan MN, Sikic BI. 1991. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin. Cancer Res 51:5181-5187.
22. Lercher MJ, Blumenthal T, Hurst LD. 2003. Coexpression of neighboring genes in Caenorhabditis elegans is mostly due to operons and duplicate genes. Genome Res 13:238-243.
23. Mickley LA, Spengler BA, Knutsen TA, Biedler JL, Fojo T. 1997. Gene rearrangement: a novel mechanism for MDR-1 gene activation. J Clin Invest 99:1947-1957.
24. Olshen AB, Venkatraman ES, Lucito R, Wigler M. 2004. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5:557-572.
25. Parekh HK, Deng HB, Choudhary K, Houser SR, Simpkins H. 2002. Overexpression of sorcin, a calcium-binding protein, induces a low level of paclitaxel resistance in human ovarian and breast cancer cells. Biochem Pharmacol 63:1149-1158.
26. Penson RT, Oliva E, Skates SJ, Glyptis T, Fuller AF Jr, Goodman A, Seiden MV. 2004. Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancel patients: a study in serial samples. Gynecol Oncol 93:98-106.
27. Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JC, Lashkari D, Shalon D, Brown PO, Botstein D. 1999. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 96:9212-9217.
28. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF, Jeffrey SS, Botstein D, Brown PO. 1999. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 23:41-46.
29. Reyal F, Stransky N, Bernard-Pierrot I, Vincent-Salomon A, de Rycke Y, Elvin P, Cassidy A, Graham A, Spraggon C, Desille Y, Fourquet A, Nos C, Pouillart P, Magdelenat H, Stoppa-Lyonnet D, Couturier J, Sigal-Zafrani B, Asselain B, Sastre-Garau X, Delattre O, Thiery JP, Radvanyi F. 2005. Visualizing chromosomes as transcriptome correlation maps: evidence of chromosomal domains containing co-expressed genes - a study of 130 invasive ductal breast carcinomas. Cancer Res 65:1376-1383.
30. Roninson IB, Pastan I, Gottesman MM. 1991. Isolation and characterization of the human MDR (P-glycoprotein) genes. In: Roninson IB, editor. Molecular and cellular biology of multidrug resistance in tumor cells. New York: Plenum Press. p 91-106.
31. Spellman PT, Rubin GM. 2002. Evidence for large domains of similarly expressed genes in the Drosophila genome. J Biol 1:5.
32. Stein WD, Litman T, Fojo T, Bates SE. 2005. Differential expression of cell adhesion genes: implications for drug resistance. Int J Cancer 113:861-865.
33. Tan Y, Li G, Zhao C, Wang J, Zhao H, Xue Y, Han M, Yang C. 2003. Expression of sorcin predicts poor outcome in acute myeloid leukemia. Leuk Res 27:125-131.
34. Thottassery JV, Zambetti GP, Arimori K, Schuetz EG, Schuetz JD. 1997. p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents. Proc Natl Acad Sci USA 94:11037-11042.
35. Vasey PA. 2003. Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies. Br J Cancer 89(Suppl 3):S23-S28.
36. Williams EJ, Bowles DJ. 2004. Coexpression of neighboring genes in the genome of Arabidopsis thaliana. Genome Res 14:1060-1067.
37. Williams RR, Broad S, Sheer D, Ragoussis J. 2002. Subchromosomal positioning of the epidermal differentiation complex (EDC) in keratinocyte and lymphoblast interphase nuclei. Exp Cell Res 272:163-175.
38. Zhou Y, Luoh SM, Zhang Y, Watanabe C, Wu TD, Ostland M, Wood WI, Zhang Z. 2003. Genome-wide identification of chromosomal regions of increased tumor expression by transcriptome analysis. Cancer Res 63:5781-5784.